CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
- Author:
Chao LI
1
;
Eleanor BRANT
2
;
Hikmet BUDAK
3
;
Baohong ZHANG
4
Author Information
- Publication Type:Review
- Keywords: Cancer; Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas); Coronavirus disease 2019 (COVID-19); Crop improvement; Gene knock-out/in; Gene repair/replacement; Genome editing; Precision breeding
- MeSH: CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Crops, Agricultural/genetics*; Gene Editing/methods*; Genetic Therapy; Humans; Nobel Prize; Plant Breeding
- From: Journal of Zhejiang University. Science. B 2021;22(4):253-284
- CountryChina
- Language:English
- Abstract: Since it was first recognized in bacteria and archaea as a mechanism for innate viral immunity in the early 2010s, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) has rapidly been developed into a robust, multifunctional genome editing tool with many uses. Following the discovery of the initial CRISPR/Cas-based system, the technology has been advanced to facilitate a multitude of different functions. These include development as a base editor, prime editor, epigenetic editor, and CRISPR interference (CRISPRi) and CRISPR activator (CRISPRa) gene regulators. It can also be used for chromatin and RNA targeting and imaging. Its applications have proved revolutionary across numerous biological fields, especially in biomedical and agricultural improvement. As a diagnostic tool, CRISPR has been developed to aid the detection and screening of both human and plant diseases, and has even been applied during the current coronavirus disease 2019 (COVID-19) pandemic. CRISPR/Cas is also being trialed as a new form of gene therapy for treating various human diseases, including cancers, and has aided drug development. In terms of agricultural breeding, precise targeting of biological pathways via CRISPR/Cas has been key to regulating molecular biosynthesis and allowing modification of proteins, starch, oil, and other functional components for crop improvement. Adding to this, CRISPR/Cas has been shown capable of significantly enhancing both plant tolerance to environmental stresses and overall crop yield via the targeting of various agronomically important gene regulators. Looking to the future, increasing the efficiency and precision of CRISPR/Cas delivery systems and limiting off-target activity are two major challenges for wider application of the technology. This review provides an in-depth overview of current CRISPR development, including the advantages and disadvantages of the technology, recent applications, and future considerations.
